Sign up to save your podcasts
Or
Share EXPIRING SOON! Schizophrenia Update: Module 2: Advances in Long-Acting Injectables
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
EXPIRING SOON! Schizophrenia Update: Module 2: Advances in Long-Acting Injectables
Adherence to oral antipsychotics is frequently disrupted by complex dosing schedules and side effects. This module examines the clinical benefits of long-acting injectables (LAIs), including steadier blood concentrations and improved patient tolerance. Learn how the latest LAI formulations can transform treatment adherence and long-term stability. After listening, be sure to move on to Module 3 to learn about emerging treatments for cognitive symptoms.
Note: This podcast expires on 2/17. Click the link below to claim your CME/NCPD/CPE credit.
https://bit.ly/436dYa5
View all episodes
By i3 Health
4.4
1212 ratings
Adherence to oral antipsychotics is frequently disrupted by complex dosing schedules and side effects. This module examines the clinical benefits of long-acting injectables (LAIs), including steadier blood concentrations and improved patient tolerance. Learn how the latest LAI formulations can transform treatment adherence and long-term stability. After listening, be sure to move on to Module 3 to learn about emerging treatments for cognitive symptoms.
Note: This podcast expires on 2/17. Click the link below to claim your CME/NCPD/CPE credit.
https://bit.ly/436dYa5
More shows like Oncology Data Advisor
View all
The Daily
113,129 Listeners
The ONS Podcast
206 Listeners
Huberman Lab
29,297 Listeners
Mast Cell Matters: Deep dives on MCAS with Tania Dempsey, MD - Presented by The POTScast
28 Listeners